Emma Nicholson

1.7k total citations
38 papers, 527 citations indexed

About

Emma Nicholson is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Emma Nicholson has authored 38 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Immunology and 13 papers in Hematology. Recurrent topics in Emma Nicholson's work include CAR-T cell therapy research (12 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). Emma Nicholson is often cited by papers focused on CAR-T cell therapy research (12 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). Emma Nicholson collaborates with scholars based in United Kingdom, France and United States. Emma Nicholson's co-authors include Tessa L. Holyoake, Joseph Sodroski, Bijan Etemad-Moghadam, Ying Sun, Juliette Lee, Raul Gomila, Gunilla B. Karlsson, Dominik Schenten, Paolo Gallipoli and Hilliard F. Seigler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Emma Nicholson

28 papers receiving 523 citations

Peers

Countries citing papers authored by Emma Nicholson

Since Specialization

Citations

This map shows the geographic impact of Emma Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Nicholson more than expected).

Fields of papers citing papers by Emma Nicholson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Nicholson. The network helps show where Emma Nicholson may publish in the future.

Co-authorship network of co-authors of Emma Nicholson

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Nicholson. A scholar is included among the top collaborators of Emma Nicholson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Nicholson. Emma Nicholson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWP 2026 ·Bone Marrow Transplantation ·(unknown), Ali Bazarbachi, Ambroise Marçais, (unknown), (unknown), Arian Laurence, Victoria Potter, (unknown), (unknown), Lucy Cook, (unknown), Emma Nicholson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anna Sureda	0
2	Excellent Outcomes in Patients Receiving Tisagenlecleucel for R/R B-Cell ALL: Results from the European Post-Authorization Safety Study (PASS), on Behalf of the Ctiwp, PDWP and ALWP of the EBMT. 2025 ·Transplantation and Cellular Therapy ·Krzysztof Kałwak, Annalisa Ruggeri, (unknown), (unknown), Isabel Sánchez‐Ortega, Chiara Bonini, Éolia Brissot, Tayfun Güngör, Peter Bader, Friso Calkoen, Henrik Sengeloev, Michael Daskalakis, Stephen Robinson, (unknown), Emma Nicholson, Anne Sîrvent, Jürgen Kuball, Fabio Ciceri, Christian Chabannon, (unknown)	0
3	77 \| OUTCOMES OF CAR T‐CELL THERAPY VERSUS AUTOLOGOUS HSCT IN PATIENTS WITH LARGE B‐CELL LYMPHOMA IN COMPLETE REMISSION: AN ANALYSIS FROM THE EBMT LYMPHOMA WORKING PARTY 2025 ·Hematological Oncology ·Rémy Duléry, (unknown), (unknown), (unknown), Emma Nicholson, Didier Blaise, Charles Herbaux, H. Ghesquières, Tsila Zuckerman, Keith Wilson, (unknown), Victoria Potter, Bruno Lioure, (unknown), (unknown), Ali Bazarbachi	0
4	Evaluating Axatilimab as a treatment option for chronic graft-versus-host disease 2025 ·Immunotherapy ·(unknown), Chloe Anthias, Emma Nicholson	0
5	Intestinal M icrobiota Transplant Prior to A llogeneic S tem Cell T ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial 2024 ·BMJ Open ·Benjamin H. Mullish, Andrew J. Innes, Lauren A. Roberts, (unknown), (unknown), Nicholas Johnson, Rohma Ghani, (unknown), A. Khan, Francesca Kinsella, Panagiotis Kottaridis, Pramila Krishnamurthy, Emma Nicholson, (unknown), Graham Wheeler, Frances Davies, Julian R. Marchesi, Jiří Pavlů	1
6	Outcome of Patients with HTLV-1 Adult T-Cell Leukemia/Lymphoma (ATL) after Allogeneic SCT: Results of the EBMT LWP 2024 ·Blood ·Patricia López, Ali Bazarbachi, Ambroise Marçais, (unknown), (unknown), Ben Carpenter, Victoria Potter, (unknown), Alina Tănase, Lucy Cook, Francesca Kinsella, Emma Nicholson, Annoek E. C. Broers, Jennifer Clay, (unknown), (unknown), (unknown), Olivier Hermine, (unknown)	0
7	Practice guideline: Preparation for CAR T‐cell therapy in children and young adults with B‐acute lymphoblastic leukaemia 2024 ·British Journal of Haematology ·(unknown), (unknown), (unknown), Maeve O’Reilly, Michelle Cummins, Emma Nicholson, (unknown), Denise Bonney, Geoff Shenton, David I. Marks, Persis Amrolia, Rachael Hough, Sara Ghorashian	1
8	Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 2024 ·American Journal of Hematology ·Frédéric Baron, Myriam Labopin, Jurjen Versluis, Jan Vydra, Peter A. von dem Borne, Emma Nicholson, Didier Blaise, Rachel Protheroe, Alexander Kulagin, Claude‐Eric Bulabois, Montserrat Rovira, Patrice Chevallier, Édouard Forcade, Jenny Byrne, Jaime Sanz, Annalisa Ruggeri, (unknown), Fabio Ciceri	0
9	Excellent Outcomes with Brentuximab-Nivolumab for Relapsed/ Refractory Primary Mediastinal B-Cell Lymphoma in the Real-World Setting 2024 ·Blood ·(unknown), (unknown), (unknown), Michael Potter, Emma Nicholson, Ian Chau, David Cunningham, (unknown), (unknown), Sunil Iyengar, Dima El‐Sharkawi	0
10	Real‐world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies 2024 ·British Journal of Haematology ·Abbie Wilson, Ahmed Moussa, Amélie Trinquand, (unknown), Sanjay Tewari, Richard J. Calvert, Katharine Patrick, Emma Nicholson, (unknown), Victoria Grandage, Susan Baird, Lindsay George, Amrana Qureshi, (unknown), Brenda Gibson, (unknown), Jack Bartram, (unknown), David O’Connor	0
11	A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia 2023 ·Clinical Lymphoma Myeloma & Leukemia ·Jan Vydra, Emilio Cosimo, Petr Lesný, (unknown), John Anderson, (unknown), (unknown), Emma Nicholson, (unknown)	22
12	Management of adult patients with haematological malignancies in critical care 2023 ·Anaesthesia ·(unknown), (unknown), Shaman Jhanji, Emma Nicholson, Ben Creagh‐Brown	6
13	Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation 2022 ·Haematologica ·Toby A. Eyre, Sally F. Barrington, Jessica Okosun, (unknown), Rachel M. Pearce, Jungwha Lee, Ben Carpenter, Charles Crawley, Adrian Bloor, Maria Gilleece, Emma Nicholson, Nimish Shah, Kim Orchard, Ram Malladi, William Townsend	3
14	A Wolf in Sheep's Clothing: Systemic Immune Activation Post Immunotherapy 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Abhijit Pal, Andrea Biondo, Alex Pui‐Wai Lee, Nina Tunariu, Shaman Jhanji, (unknown), Kate Tatham, Pascale Gruber, Udai Banerji, Johann S. de Bono, Emma Nicholson, Anna Minchom, Juanita Lopez	5
15	Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique 2021 ·Radiotherapy and Oncology ·Emily Durie, Emma Nicholson, Chloe Anthias, (unknown), Mike Potter, Mark Ethell, Christina Messiou, (unknown), (unknown), James Talbot, G. Smyth, (unknown), Frank Saran, Henry Mandeville	7
16	Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients 2021 ·Transplantation and Cellular Therapy ·(unknown), Robyn Shea, (unknown), (unknown), (unknown), (unknown), (unknown), Mark Ethell, Mike Potter, Carlos Arias, Chloe Anthias, Emma Nicholson	24
17	1557O Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study 2021 ·Annals of Oncology ·(unknown), Annika Fendler, Lewis Au, Fiona Byrne, Katalin A. Wilkinson, Mary Wu, Andreas M. Schmitt, Nalinie Joharatnam‐Hogan, Benjamin Shum, Lyra Del Rosario, Kim Edmonds, Eleanor Carlyle, Emma Nicholson, Michael Howell, Charles Swanton, Susanne N. Walker, George Kassiotis, Robert J. Wilkinson, James Larkin, Samra Turajlic	10
18	Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia 2009 ·Haematologica ·Dragana Milojković, Emma Nicholson, Jane F. Apperley, Tessa L. Holyoake, P Shepherd, Mark W. Drummond, Richard Szydlo, M Bua, (unknown), Alistair Reid, Jamshid S. Khorashad, Hugues de Lavallade, Katy Rezvani, Christos Paliompeis, J M Goldman, David Marin	80
19	Targeted therapy in haematological malignancies 2009 ·The Journal of Pathology ·Ashley Hamilton, Paolo Gallipoli, Emma Nicholson, Tessa L. Holyoake	29
20	Envelope Glycoprotein Determinants of Increased Fusogenicity in a Pathogenic Simian-Human Immunodeficiency Virus (SHIV-KB9) Passaged In Vivo 2000 ·Journal of Virology ·Bijan Etemad-Moghadam, Ying Sun, Emma Nicholson, (unknown), (unknown), Raul Gomila, Juliette Lee, Joseph Sodroski	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact